journal of molecular catalysis b-enzymatic-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

SCI期刊是如何分区的？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-29 Mia

选刊时需结合分区进行吗？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2018-05-09 lovetcm

已被踢出SCI收录了，大家小心

293 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2016-09-29 ms5891867453131702

jul 26 2015 submitted
aug 2 2015 under review
sep 16 2015 with editor evaluation
sep 30 2015 minor revision
oct 2 2015 submitted revised manuscript
nov 1 2015 accept

141 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2015-07-12 tonycjlu

审稿速度:1.0 | 投稿命中率:50.0
经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！
刚刚中了一篇，对新颖有一定的要求，
语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。

希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。

414 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2013-04-14 ms8933482113232354

投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless.........

96 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2013-04-06 匿名用户

投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。

494 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2013-01-10 ms9051856686409430

我的在一月除投的，四月能被接受吗

94 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2012-12-18 ms622773450447966

期刊质量不错，只是审稿速度有点慢，可能是我运气不好。

88 0

[GetPortalCommentsPageByObjectIdResponse(id=1093693, encodeId=261a109369311, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093694, encodeId=dcad1093694ca, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555887, encodeId=bb2b55588e48, content=已被踢出SCI收录了，大家小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 09 17:41:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834052, encodeId=919f83405298, content=jul 26 2015 submitted aug 2 2015 under review sep 16 2015 with editor evaluation sep 30 2015 minor revision oct 2 2015 submitted revised manuscript nov 1 2015 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a65414122, createdName=ms5891867453131702, createdTime=Thu Sep 29 18:24:34 CST 2016, time=2016-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513439, encodeId=717f5134395a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：研究酶的人都中意的杂志，不知道为什么IF一下子降低这么多，估计三区难保！ 刚刚中了一篇，对新颖有一定的要求， 语言最好先找专业公司修改，附上修改证明，这样能加快审稿速度。现在多数杂志对非英语母语稿件的歧视有点严重，有的直接拒绝送审。 希望Enzymatic的IF明年能上去。相对其他Catalysis的杂志，他的IF真是很低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Sun Jul 12 17:12:00 CST 2015, time=2015-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=825122, encodeId=2b148251223f, content=投了一篇，两个审稿人，under review 一个月之后，两个审稿人，一个同意接受，一个拒稿，编辑给了大修，重新审稿。目前修回重审中，bless......... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Sun Apr 14 21:27:00 CST 2013, time=2013-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494872, encodeId=fb964948e222, content=投稿5周后，现在的状态是required reviews completed，等待审稿结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Apr 06 05:40:00 CST 2013, time=2013-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823483, encodeId=8bb48234839c, content=我的在一月除投的，四月能被接受吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Thu Jan 10 11:48:00 CST 2013, time=2013-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823085, encodeId=cb00823085b8, content=期刊质量不错，只是审稿速度有点慢，可能是我运气不好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Tue Dec 18 13:25:00 CST 2012, time=2012-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492445, encodeId=865349244536, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2012-11-28 qupeter

明年能不能冲到3分？大家谈谈

396 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务